You are here

  • Home
  • Archive
  • Volume 33, Issue Suppl 4
  • PR072/#1519  Effort: clinical and molecular features associated with clinical benefit from adavosertib with or without olaparib in recurrent ovarian cancer following progression on PARP inhibition (NCT03579316)

Article metrics

Article menu

Download PDFPDF

Featured Posters: Poster Rounds with the Professors
AS11. Ovarian cancer
PR072/#1519  Effort: clinical and molecular features associated with clinical benefit from adavosertib with or without olaparib in recurrent ovarian cancer following progression on PARP inhibition (NCT03579316)
Free

 

Online download statistics by month:

Online download statistics by month: November 2023 to October 2024

AbstractFullPdf
Nov 2023113039
Dec 202361013
Jan 20242707
Feb 20244103
Mar 202472014
Apr 20242002
May 20241804
Jun 20242207
Jul 20243207
Aug 20241205
Sep 20241304
Oct 20241600
Total4470105